Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Surging prevalence of bacterial and viral infections
3.2.1.2 Increasing aquaculture production across the globe
3.2.1.3 Development and launch of new aquaculture vaccines
3.2.1.4 Rising adoption of aquaculture vaccines over antibiotics
3.2.2 Industry pitfalls and challenges
3.2.2.1 Stringent regulatory policies for vaccine approval
3.2.2.2 Complex vaccine development procedures
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Pipeline analysis
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Vaccine Type, 2021 – 2034 ($ Mn)
5.1 Key trends
5.2 Inactivated vaccine
5.3 Live attenuated vaccine
5.4 Subunit vaccine
5.5 Other vaccine types
Chapter 6 Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
6.1 Key trends
6.2 Injection vaccines
6.3 Immersion and spray
6.4 Oral vaccines
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
7.1 Key trends
7.2 Bacterial
7.3 Viral
7.4 Parasitic
7.5 Combined
Chapter 8 Market Estimates and Forecast, By Species, 2021 – 2034 ($ Mn)
8.1 Key trends
8.2 Salmon
8.3 Trout
8.4 Tilapia
8.5 Seabass
8.6 Seabream
8.7 Turbot
8.8 Carp
8.9 Other species
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Norway
9.3.7 Ireland
9.3.8 Turkey
9.3.9 Denmark
9.4 Asia Pacific
9.4.1 China
9.4.2 India
9.4.3 Indonesia
9.4.4 Philippines
9.4.5 Thailand
9.4.6 Vietnam
9.4.7 Australia
9.4.8 New Zealand
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Chile
9.6 Middle East and Africa
9.6.1 Iran
9.6.2 Egypt
Chapter 10 Company Profiles
10.1 CIBA
10.2 HIPRA
10.3 Kyoto Biken Laboratories
10.4 Kemin Industries
10.5 Kyoritsuseiyaku Corporation
10.6 Merck Animal Health (Merck & Co.)
10.7 Nisseiken
10.8 Phibro Animal Health Corporation
10.9 Tecnovax
10.10 Virbac
10.11 Veterquimica
10.12 Vaxxinova International
10.13 Zoetis
